MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 16, Issue 4, Pages 739-751

出版商

American Association for Cancer Research (AACR)

发表日期

2017-01-10

DOI

10.1158/1535-7163.mct-16-0591

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started